Katharine E. Spink, Chief Operating Officer at Asterias Biotherapeutics, Inc. (AST), sold 19,336 shares at $3.54 ($68K) on 2016-09-09, disclosed to the SEC on 2016-09-12.
Scheduled sale ($68k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.50 | 9,728 | $34K | 50.0% |
| 2 | $3.54 | 9,608 | $34K | 50.0% |
| Total | $3.52 avg | 19,336 | $68K | 100% |
| Filing → |
| AST | SELL | 2016-11-28 | $14K | — | Filing → |
| AST | SELL | 2016-11-21 | $13K | — | Filing → |
| AST | SELL | 2016-10-11 | $39K | — | Filing → |